Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes Mellitus Among the Adult Residents of Tehran: Tehran Cohort Study Publisher Pubmed



Oraii A1 ; Shafiee A1 ; Jalali A1 ; Alaeddini F1 ; Saadat S2 ; Masoudkabir F1, 3 ; Vasheghanifarahani A1, 3 ; Heidari A3, 4 ; Sadeghian S1 ; Boroumand M1 ; Karimi A1 ; H Franco O5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Emergency Medicine, University of California, Irvine, CA, United States
  3. 3. Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  5. 5. Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland

Source: BMC Endocrine Disorders Published:2022


Abstract

Background: The prevalence of type 2 diabetes mellitus has increased in the past decades. We investigated the prevalence of diabetes and its awareness, treatment, and control among adult residents of Tehran. Methods: We used the recruitment phase data of the Tehran Cohort study, enrolling a random sample of adult residents of Tehran aged ≥35 years. Diabetes was defined as self-report, current use of glucose-lowering medications, and/or fasting plasma glucose (FPG) ≥126mg/dl. Impaired fasting glucose (IFG) was defined as an FPG of 100-125mg/dl. Awareness was defined as diabetes self-report, treatment as receiving glucose-lowering medications, and glycemic control as FPG <126mg/dl. The age- and sex-weighted estimates were calculated using the 2016 national census. Logistic regression models were used to determine the factors associated with diabetes awareness, treatment, and control. Results: A total of 8151 participants were included. Age- and sex-weighted prevalence of diabetes mellitus and IFG were 16.7% (95% CI: 15.1–18.4) and 25.1% (95% CI: 23.1–27.1), respectively. Diabetes was more prevalent in the eastern and central districts of Tehran. Advanced age (OR per 1-year increase: 1.026, 95% CI: 1.021-1.030), male sex (OR: 1.716, 95% CI: 1.543-1.909), higher BMI levels (OR for BMI ≥35 vs. <20 kg/m2: 4.852, 95% CI: 3.365-6.998), pre-existing hypertension (OR: 1.552, 95% CI: 1.378-1.747), dyslipidemia (OR: 1.692, 95% CI: 1.521-1.883), and chronic kidney disease (OR: 1.650, 95% CI: 1.019-2.673) were associated with an increased odds of diabetes mellitus. On the contrary, diabetes mellitus was less likely in current tobacco (OR: 0.872, 95% CI: 0.765-0.994) and alcohol users (OR: 0.836, 95% CI: 0.703-0.994) compared to non-users. Among diabetic individuals, 82.8% were aware of their condition, 71.9% received treatment, and 31.7% of treated patients had adequate glycemic control. Advanced age and pre-existing comorbidities, including hypertension and dyslipidemia, were associated with higher diabetes awareness and treatment. Furthermore, advanced age, higher levels of education, and female sex were determinants of better glycemic control among treated diabetic participants. Conclusion: There is a high prevalence of diabetes and IFG among adult residents of Tehran. Additionally, more than two-thirds of treated diabetics living in Tehran remain uncontrolled. © 2022, The Author(s).
Other Related Docs
18. Iran Diabetes Research Study; Knowledge Discovery in Diagnosis: A Scoping Review, Journal of Diabetes and Metabolic Disorders (2021)
24. Diabetes Mellitus and Its Risk Factors Among a Middle-Aged Population of Iran, a Population-Based Study, International Journal of Diabetes in Developing Countries (2016)
30. Diabetes and Heart Failure: Multi-Omics Approaches, Frontiers in Physiology (2021)
34. Knowledge Discovery in Genetics of Diabetes in Iran, a Roadmap for Future Researches, Journal of Diabetes and Metabolic Disorders (2021)
41. Technology Contribution to Prevention of Noncommunicable Diseases, Iranian Journal of Kidney Diseases (2015)
49. Glycemic Index (Gi) Values for Major Sources of Dietary Carbohydrates in Iran, International Journal of Endocrinology and Metabolism (2020)
50. The Persian Guilan Cohort Study (Pgcs), Archives of Iranian Medicine (2019)